Posaconazole Tablet, Coated
Product Images NDC 0254-2045

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 0254-2045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Endo Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Posaconazole 01)

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Principal Display Panel (100 mg Tablet Bottle Label)
This is a medication information label for delayed-release Posaconazole tablets with the National Drug Code (NDC) 0254-2045-02. Each tablet contains 100 mg posaconazole, and the usual dosage is mentioned in the package insert. The label warns that Posaconazoe Oral Suspension and Delayed-Release Tablets are not interchangeable due to differences in dosing for each format. The product is manufactured in Ireland or the Netherlands and imported by IPAR in Chestnut Ridge, NY. The Global Trade Item Number (GTIN) and the storage temperature range are also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.